The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-benzyl-2-(3-benzylisoxazol-5-yl)-4-methylthiazole-5-carboxamide ID: ALA3104611
PubChem CID: 24960062
Max Phase: Preclinical
Molecular Formula: C22H19N3O2S
Molecular Weight: 389.48
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1nc(-c2cc(Cc3ccccc3)no2)sc1C(=O)NCc1ccccc1
Standard InChI: InChI=1S/C22H19N3O2S/c1-15-20(21(26)23-14-17-10-6-3-7-11-17)28-22(24-15)19-13-18(25-27-19)12-16-8-4-2-5-9-16/h2-11,13H,12,14H2,1H3,(H,23,26)
Standard InChI Key: VVCCFRMGZHTIFG-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
12.9168 -5.3076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9157 -6.1271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6237 -6.5361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3334 -6.1266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3305 -5.3040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6219 -4.8987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0417 -6.5341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7488 -6.1244 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4571 -6.5319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1642 -6.1222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4584 -7.3491 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.9069 -6.4546 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.4527 -5.8464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0430 -5.1393 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2440 -5.3106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6344 -4.7664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2671 -5.9248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6769 -6.6319 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.4759 -6.4607 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5601 -5.6478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8130 -5.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2671 -5.2380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9755 -5.6455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9720 -6.4602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6795 -6.8675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3875 -6.4577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3835 -5.6363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6754 -5.2327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
10 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 10 2 0
15 16 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 17 2 0
13 17 1 0
20 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 389.48Molecular Weight (Monoisotopic): 389.1198AlogP: 4.63#Rotatable Bonds: 6Polar Surface Area: 68.02Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.17CX Basic pKa: ┄CX LogP: 3.97CX LogD: 3.97Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -1.81
References 1. Sun S, Zhang Z, Kodumuru V, Pokrovskaia N, Fonarev J, Jia Q, Leung PY, Tran J, Ratkay LG, McLaren DG, Radomski C, Chowdhury S, Fu J, Hubbard B, Winther MD, Dales NA.. (2014) Systematic evaluation of amide bioisosteres leading to the discovery of novel and potent thiazolylimidazolidinone inhibitors of SCD1 for the treatment of metabolic diseases., 24 (2): [PMID:24374272 ] [10.1016/j.bmcl.2013.12.036 ]